Changing our understanding of childhood brain tumours and how to treat them
Source: Health E-News and Canadian Cancer Society. Dr. Nada Jabado, senior scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), and her colleague Claudia Kleinman, PhD, assistant professor in the Department of Human Genetics at McGill University, are among seven prominent Canadian researchers recognized by the Canadian Cancer Society (CCS). Both received a 2020 CCS Award for Excellence for their bold leadership and trailblazing contributions to drive progress in multiple areas of cancer research.
Dr. Jabado, who is also a professor in the Department of Pediatrics and Human Genetics at McGill University, is the recipient of the Robert L. Noble Prize for discovering that brain tumours in children are fundamentally distinct from the same tumours found in adults and that nearly half of pediatric glioblastomas, an aggressive type of brain tumour, are caused by mutations in genes that affect how DNA is structured and organized.
“As a world leader in pediatric brain cancer research, Dr. Jabado’s work has fundamentally changed our understanding of these tumours and how they should be treated,” notes Dr. Stuart Edmonds, Executive Vice-President, Mission, Research and Advocacy at CCS. “We applaud Dr. Jabado’s commitment to driving progress so that more children with brain tumours can live longer, fuller lives.” Read more
May 12, 2021
Related news
Researchers identify the origin of a deadly brain cancer
Nada Jabado and Claudia Kleinman part of team shortlisted for Cancer Grand Challenges awards